HomeSOLV • NYSE
add
Solventum Corp
Previous close
$65.01
Day range
$64.29 - $66.85
Year range
$60.72 - $72.40
Market cap
11.25B USD
Avg Volume
2.58M
P/E ratio
8.35
Dividend yield
-
Primary exchange
NYSE
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 2.04B | 1.55% |
Operating expense | 794.00M | 9.22% |
Net income | 272.00M | -11.40% |
Net profit margin | 13.36 | -12.74% |
Earnings per share | — | — |
EBITDA | 503.00M | -5.63% |
Effective tax rate | 30.43% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 194.00M | 218.03% |
Total assets | 13.94B | 2.57% |
Total liabilities | 2.28B | 22.95% |
Total equity | 11.67B | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | 6.65% | — |
Return on capital | 7.80% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 272.00M | -11.40% |
Cash from operations | 547.00M | 22.65% |
Cash from investing | -88.00M | -7.32% |
Cash from financing | -306.00M | 14.04% |
Net change in cash | 152.00M | 2,071.43% |
Free cash flow | 473.50M | — |
About
Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024. Wikipedia
Founded
2023
Headquarters
Website
Employees
22,007